Efficacy and Safety of Bevacizumab Plus Erlotinib in Patients with Renal Medullary Carcinoma.
Wiele AJ, Surasi DS, Rao P, Sircar K, Su X, Bathala TK, Shah AY, Jonasch E, Cataldo VD, Genovese G, Karam JA, Wood CG, Tannir NM, Msaouel P.
Wiele AJ, et al. Among authors: tannir nm.
Cancers (Basel). 2021 Apr 30;13(9):2170. doi: 10.3390/cancers13092170.
Cancers (Basel). 2021.
PMID: 33946504
Free PMC article.